Navigation Links
BioLife Solutions Presents Data on CryoStor at International,Society for Cellular Therapy Annual Meeting

ion-induced, delayed-onset cell damage and death. BioLife's enabling technology provides academic and clinical researchers significant improvements in post-thaw cell, tissue, and organ viability and function. For more information please visit http://www.biolifesolutions.com.

This news release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements include any statements that relate to the intent, belief, plans or expectations of the Company or its management, or that are not a statement of historical fact. Any forward-looking statements in this news release are based on current expectations and beliefs and are subject to numerous risks and uncertainties that could cause actual results to differ materially. Some of the specific factors that could cause BioLife Solutions' actual results to differ materially are discussed in the Company's recent filings with the Securities and Exchange Commission. BioLife Solutions disclaims any obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.

    Media Relations:                  Investor Relations:

    Len Hall                          Matt Clawson

    Allen & Caron Inc.                Allen & Caron Inc.

    (949) 474-4300                    (949) 474-4300
len@allencaron.com matt@allencaron.com

CONTACT: Media Relations, Len Hall, , or InvestorRelations, Matt Clawson, , both of Allen & Caron Inc.,+1-949-474-4300, for BioLife Solutions Inc. len@allencaron.com matt@allencaron.com

Web site:




Page: 1 2 3 4

Related medicine technology :

1. Ties Between Physicians and Drug Companies Still Too Strong: the Prescription Project Offers Solutions to Prevent Conflicts of Interest
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
4. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
5. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
6. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
7. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
8. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
9. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
10. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein
11. BioCryst Presents Phase I Peramivir Data at the Options for the Control of Influenza Conference
Post Your Comments:
(Date:12/1/2008)...Dec. 1 Vical Incorporate... a $1.0 million milestone payment from Merck &...a Phase I clinical trial of an investigational pla...ine is based on Vical,s DNA gene delivery technolo...ase (hTERT). hTERT is the subject of separate lice...
(Date:11/28/2008)...Z, Germany, November 28 German bio...rship in specialized HIV monitoring and,AIDS pati...ing countries. In,the year 2008, 2.5 million pati...robust and highly affordable "CyFlow" system, supp...with HIV/AIDS. Due to introduction of the,Partec ...
(Date:11/26/2008)...Minn., Nov. 26 Children...t significantly increased risk of developing menta...s of a Mayo Clinic study published this month in ...Academy of Pediatrics. , , The retrospectiv...ts with strabismus (misaligned eyes) and compared ...
(Date:11/25/2008)...reness can improve recovery , , Audio and W...ilable on the Mayo Clinic News Blog. Please see th..., ROCHESTER, Minn., Nov. 25 /PRNewswire-USNewswi...oke patients don,t think they,re having a stroke -... their condition worsens. The findings appear in t...
Breaking Medicine Technology:Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2Eye Divergence in Children Triples Risk of Mental Illness 2Do You Know You're Having a Stroke? 2Do You Know You're Having a Stroke? 3IOS Press congratulates IPCC with Nobel Peace Prize 1518 1Group Seeks Refinement of Knee Arthritis Treatment Guidelines 7942 1Group Seeks Refinement of Knee Arthritis Treatment Guidelines 7942 2DelSite Nasal Powder Technology Could Reduce Recently Reported Waste in Federal Vaccine Program 2116 1DelSite Nasal Powder Technology Could Reduce Recently Reported Waste in Federal Vaccine Program 2116 2DelSite Nasal Powder Technology Could Reduce Recently Reported Waste in Federal Vaccine Program 2116 3Pharmos Corporation to Present at the 2007 RBC Capital Markets Healthcare Conference 2114 1Pharmos Corporation to Present at the 2007 RBC Capital Markets Healthcare Conference 2114 2
...2, 2007 - Ceragenix Pharmaceuticals,Inc. (OTCBB:C...tious disease and dermatology, today announced tha...onstrated virtually no biofilm,formation in a 21 d...eated with Ceragenins,were soaked daily in a phosp...heter. At day 21, the catheters were challenged wi...
..., 2007: Progen Industries Limited,(ASX: PGL; NASDA...se II liver cancer data has been accepted for late...ation for the Study of the Liver,(EASL). Progen wi...ncer trial at the American Association for Cancer ...ation of having final data fully analysed and read...
Other Medicine Technology:Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm,Formation in 21 Day Study 2Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm,Formation in 21 Day Study 3PI-88 Data to be Presented at Key International Conferences 2PI-88 Data to be Presented at Key International Conferences 3
(Date:12/2/2008)... Fellow occupants can help keep driving safe, rese...y News) -- Drivers talking on a cell phone are mor...were speaking with a friend sitting next to them i...s basically a process of joint attention, so when ...ienced as a driver, that person actually understan...
(Date:12/2/2008)... With new naming structure, Kessler Foundation con...disabilities , , WEST ORANGE, N.J.Dec. 2 /P...rting people with physical disabilities, Henry H. ...on,s new name -- Kessler Foundation. The Foundatio...ions to Kessler Foundation Research Center and Kes...
(Date:12/2/2008)... -Survey Reveals Nearly Half Have Skipped Medical ..., Dec. 2 A new survey r...rce Center (NWHRC) highlights another troubling as...ave failed to seek health care for themselves or t...te that many women say their health has gotten wor...
(Date:12/2/2008)... At Least 10 New Cellular Therapies Will Launch Ov...ision Resources , , WALTHAM, Mass., Dec. 2 ...ld,s leading research and advisory firms for pharm...llular therapies drug market will experience robus..., reaching $1.5 billion in 2017. According to the ...
Breaking Medicine News(10 mins):Health News:Car Cell Phone Use More Hazardous Than Chat With Passengers 2Health News:Car Cell Phone Use More Hazardous Than Chat With Passengers 3Health News:Henry H. Kessler Foundation Rebranded as Kessler Foundation 2Health News:Henry H. Kessler Foundation Rebranded as Kessler Foundation 3Health News:Rising Health Costs Prompt Women to Neglect Health 2Health News:Rising Health Costs Prompt Women to Neglect Health 3Health News:Rising Health Costs Prompt Women to Neglect Health 4Health News:Market for Cellular Therapies Will Grow at a Robust Annual Rate of More Than 30 Percent in the United States Through 2017 2
...(SAD) is not all that well understood, but is beli...inter months. Winter depression involves suffering...he days get longer and nights get shorter. Other S...h carbohydrate foods, and sleeping for longer than...
...a patient, a two-month-old baby with white blood! ...ase caused due to a deficiency of lipoprotein lipa...ion children. Doctors said that the baby was broug...ool. On detection the baby, a boy child, was found...
...olet rays, has always been said to be bad for one'... has shown that even moderate sun exposure can res...eadliest form of skin cancer. Exposure to sun has ...r, but the link between sun exposure and melanoma,...
... there is a metabolic threshold that occurs in you...tivity becomes deleterious for lumbar bone mineral...he researchers, over a 10-year period, investigate...sical activity and LBMD in 225 men and 241 women. ...
Other Medicine News:
Portable - Battery Powered (6 size AA required). Fast, Lightweight Strain Gage Mechanism. Unit conversion (g, ct, oz, ozt, GN, dwt, mom, dwt, tael), Specific Gravity calculation, Piece Counting and P
Portable - Battery Powered (6 size AA required). Fast, Lightweight Strain Gage Mechanism. Unit conversion (g, ct, oz, ozt, GN, dwt, mom, dwt, tael), Specific Gravity calculation, Piece Counting and P
Small, comes in a compact carrying case, carrying pouch included.
60 month warranty, constructed entirely of aluminum alloy, allows the selection of 11 units of measure.
Medicine Products: